Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other 1Breast 1

Conditions

Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Family Characteristics × Clear all
NCT03489057 2024-10-03

Efficacy of a Couple-Focused mHealth Symptom Self-management Program

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
560 enrolled 29 charts
Genitourinary

Prostatic Neoplasms

NCT03177707 2019-10-02

IMPPACT

Vancouver Prostate Centre

Phase NA Completed
28 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT01342302 2013-04-10

OPIC

Sunnybrook Health Sciences Centre

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡